Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/26/2026

1. ON
2. SYNA
3. SPY
4. MU
5. DRI
6. NVDA
7. FDXF
8. NKE
9. MKC
10. SPCX

Go back to Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®
(NASDAQ: PSNL) Delayed: 13.08 +0.49 (3.89%)
Previous Close $12.59    52 Week High $ 
Open $12.50    52 Week Low $ 
Day High $13.37    P/E N/A 
Day Low $12.26    EPS $ 
Volume 1,773,265